These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32549098)

  • 21. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
    Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
    Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting.
    Liu H; Yan X; Yu J
    J Clin Lab Anal; 2020 Jul; 34(7):e23299. PubMed ID: 32185824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can red blood cell distribution width predict long-term cardiovascular event after off-pump coronary artery bypass? A retrospective study.
    Wu H; Wang X; Zhang J; Sun H
    J Card Surg; 2019 Oct; 34(10):988-993. PubMed ID: 31478233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
    Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
    Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
    Sharma SP; Dahal K; Khatra J; Rosenfeld A; Lee J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of SYNTAX score in predicting outcome patients undergoing percutaneous coronary intervention].
    Gao YC; Yu XP; He JQ; Chen F
    Zhonghua Nei Ke Za Zhi; 2012 Jan; 51(1):31-3. PubMed ID: 22490756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction.
    Wang Q; Ma J; Jiang Z; Wu F; Ping J; Ming L
    Medicine (Baltimore); 2017 Aug; 96(34):e7897. PubMed ID: 28834908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery bypass vs percutaneous coronary intervention in under 50s.
    Shafi AMA; Dhanji AAA; Habib AM; Kennon SRO; Awad WI
    J Card Surg; 2020 Feb; 35(2):320-327. PubMed ID: 31803987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
    Ahn JM; Roh JH; Kim YH; Park DW; Yun SC; Lee PH; Chang M; Park HW; Lee SW; Lee CW; Park SW; Choo SJ; Chung C; Lee J; Lim DS; Rha SW; Lee SG; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ
    J Am Coll Cardiol; 2015 May; 65(20):2198-206. PubMed ID: 25787197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation drug-eluting stenting versus coronary artery bypass grafting for treatment of coronary chronic total occlusion.
    Jang WJ; Yang JH; Song YB; Hahn JY; Chun WJ; Oh JH; Kim WS; Lee YT; Yu CW; Lee HJ; Gwon HC; Choi SH
    J Cardiol; 2019 May; 73(5):432-437. PubMed ID: 30611686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated postoperative serum uric acid is associated with major adverse events following coronary artery bypass grafting.
    Shi Y; Zhang X; Du J; Chen S; Zhang H; Yang L; Zheng Z
    J Card Surg; 2020 Oct; 35(10):2559-2566. PubMed ID: 33043654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Coronary Dominance in Patients Undergoing Elective Coronary Artery Bypass Surgery.
    Selcuk E; Cevirme D; Bugra O
    Braz J Cardiovasc Surg; 2020 Aug; 35(4):452-458. PubMed ID: 32864923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.